Congenital disorders of estrogen biosynthesis and action.

[1]  T. Ogata,et al.  Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome , 2021, The Journal of clinical endocrinology and metabolism.

[2]  N. Vasudevan,et al.  Does GPER1 Play a Role in Sexual Dimorphism? , 2020, Frontiers in Endocrinology.

[3]  Dongmin Liu,et al.  Does GPER Really Function as a G Protein-Coupled Estrogen Receptor in vivo? , 2020, Frontiers in Endocrinology.

[4]  M. Trippel,et al.  Novel CYP19A1 Mutations Extend the Genotype-Phenotype Correlation and Reveal the Impact on Ovarian Function , 2020, Journal of the Endocrine Society.

[5]  J. Katzenellenbogen,et al.  Long-Term Follow Up and Treatment of a Female with Complete Estrogen Insensitivity. , 2020, The Journal of clinical endocrinology and metabolism.

[6]  T. Atik,et al.  Aromatase Deficiency in Two Siblings with 46,XX Karyotype Raised as Different Genders: A Novel Mutation (p.R115X) in the CYP19A1 Gene , 2020, Journal of clinical research in pediatric endocrinology.

[7]  A. Belgorosky,et al.  Estrogens in Human Male Gonadotropin Secretion and Testicular Physiology From Infancy to Late Puberty , 2020, Frontiers in Endocrinology.

[8]  S. Ferchichi,et al.  Association of genetic variants in Estrogen receptor (ESR)1 and ESR2 with susceptibility to recurrent pregnancy loss in Tunisian women: a case control study. , 2020, Gene.

[9]  A. Pask,et al.  A critical role for estrogen signaling in penis development , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  E. Levin,et al.  Impact of estrogens in males and androgens in females. , 2019, The Journal of clinical investigation.

[11]  D. Peng,et al.  The etiological effect of a new low-frequency ESR1 variant on Mild Cognitive Impairment and Alzheimer’s Disease: a population-based study , 2018, Aging.

[12]  A. Belgorosky,et al.  Accelerated Pubertal Tempo in a 46,XY Aromatase-Deficient Patient , 2018, Hormone Research in Paediatrics.

[13]  S. Ceylaner,et al.  A Novel Homozygous CYP19A1 Gene Mutation: Aromatase Deficiency Mimicking Congenital Adrenal Hyperplasia in an Infant without Obvious Maternal Virilisation , 2018, Journal of clinical research in pediatric endocrinology.

[14]  M. Lang-Muritano,et al.  Early-Onset Complete Ovarian Failure and Lack of Puberty in a Woman With Mutated Estrogen Receptor &bgr; (ESR2) , 2018, The Journal of clinical endocrinology and metabolism.

[15]  H. Onay,et al.  Aromatase Deficiency due to a Novel Mutation in CYP19A1 Gene , 2018, Journal of clinical research in pediatric endocrinology.

[16]  L. Looijenga,et al.  Biallelic and monoallelic ESR2 variants associated with 46,XY disorders of sex development , 2017, Genetics in Medicine.

[17]  G. Prins,et al.  Estrogens in Male Physiology. , 2017, Physiological reviews.

[18]  S. Hammes,et al.  Aromatase deficiency in a male patient - Case report and review of the literature. , 2016, Bone.

[19]  K. Korach,et al.  Familial Multiplicity of Estrogen Insensitivity Associated With a Loss-of-Function ESR1 Mutation , 2016, The Journal of clinical endocrinology and metabolism.

[20]  Huai-Dong Song,et al.  Aromatase deficiency: a novel compound heterozygous mutation identified in a Chinese girl with severe phenotype and obvious maternal virilization , 2016, Molecular and Cellular Endocrinology.

[21]  S. Akçurin,et al.  A Novel Null Mutation in P450 Aromatase Gene (CYP19A1) Associated with Development of Hypoplastic Ovaries in Humans , 2016, Journal of clinical research in pediatric endocrinology.

[22]  Rachel M. Brown,et al.  Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression. , 2016, Human molecular genetics.

[23]  R. Schiff,et al.  ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer , 2015, Nature Reviews Clinical Oncology.

[24]  C. Flück,et al.  Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[25]  A. Belgorosky,et al.  Five new cases of 46,XX aromatase deficiency: clinical follow-up from birth to puberty, a novel mutation, and a founder effect. , 2015, The Journal of clinical endocrinology and metabolism.

[26]  Shiuan Chen,et al.  Aromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: Effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism , 2015, Molecular and Cellular Endocrinology.

[27]  T. Ogata,et al.  Cytochrome P450 oxidoreductase deficiency: Rare congenital disorder leading to skeletal malformations and steroidogenic defects , 2014, Pediatrics international : official journal of the Japan Pediatric Society.

[28]  H. Carlson,et al.  Gynaecomastia—pathophysiology, diagnosis and treatment , 2014, Nature Reviews Endocrinology.

[29]  T. Ogata,et al.  Aromatase excess syndrome in a family with upstream deletion of CYP19A1 , 2014, Clinical endocrinology.

[30]  T. Ogata,et al.  Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis , 2014, Expert review of endocrinology & metabolism.

[31]  M. Polak,et al.  Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies , 2014, Molecular and Cellular Endocrinology.

[32]  Y. Ge,et al.  Association of polymorphisms in estrogen receptors (ESR1 and ESR2) with male infertility: a meta-analysis and systematic review , 2014, Journal of Assisted Reproduction and Genetics.

[33]  T. Ogata,et al.  Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia. , 2014, Pediatric endocrinology reviews : PER.

[34]  H. Scott,et al.  A case of Aromatase deficiency due to a novel CYP19A1 mutation , 2014, BMC Endocrine Disorders.

[35]  S. Bulun.  Aromatase and estrogen receptor α deficiency. , 2014, Fertility and sterility.

[36]  H. Burger,et al.  Genomic basis of aromatase excess syndrome: recombination- and replication-mediated rearrangements leading to CYP19A1 overexpression. , 2013, The Journal of clinical endocrinology and metabolism.

[37]  Yiping Shen,et al.  Delayed puberty and estrogen resistance in a woman with estrogen receptor α variant. , 2013, The New England journal of medicine.

[38]  M. Asadi,et al.  Estrogen receptor mutation in a girl with primary amenorrhea , 2013, Clinical genetics.

[39]  C. Flück,et al.  Impact of Estrogen Replacement throughout Childhood on Growth, Pituitary-Gonadal Axis and Bone in a 46,XX Patient with CYP19A1 Deficiency , 2012, Hormone Research in Paediatrics.

[40]  T. Ogata,et al.  Aromatase excess syndrome: identification of cryptic duplications and deletions leading to gain of function of CYP19A1 and assessment of phenotypic determinants. , 2011, The Journal of clinical endocrinology and metabolism.

[41]  W. Miller,et al.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. , 2011, Endocrine reviews.

[42]  S. Srouji,et al.  Estrogen negative feedback on gonadotropin secretion: evidence for a direct pituitary effect in women. , 2010, The Journal of clinical endocrinology and metabolism.

[43]  A. Belgorosky,et al.  Genetic and Clinical Spectrum of Aromatase Deficiency in Infancy, Childhood and Adolescence , 2009, Hormone Research in Paediatrics.

[44]  D. Kiel,et al.  Collaborative Meta-analysis: Associations of 150 Candidate Genes With Osteoporosis and Osteoporotic Fracture , 2009, Annals of Internal Medicine.

[45]  V. Rochira,et al.  Aromatase deficiency in men: a clinical perspective , 2009, Nature Reviews Endocrinology.

[46]  S. Bulun,et al.  Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene. , 2007, Human molecular genetics.

[47]  E. Simpson,et al.  A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome , 2007, Clinical endocrinology.

[48]  M. Dattani,et al.  Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. , 2007, The Journal of clinical endocrinology and metabolism.

[49]  T. Ogata,et al.  Association of cryptorchidism with a specific haplotype of the estrogen receptor alpha gene: implication for the susceptibility to estrogenic environmental endocrine disruptors. , 2005, The Journal of clinical endocrinology and metabolism.

[50]  A. Polyakov,et al.  A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome. , 2005, The Journal of clinical endocrinology and metabolism.

[51]  Bjarni V. Halldórsson,et al.  Estrogen Receptor Genotypes and Haplotypes Associated with Breast Cancer Risk , 2004, Cancer Research.

[52]  M. Grumbach.  Mutations in the Synthesis and Action of Estrogen: The Critical Role in the Male of Estrogen on Pubertal Growth, Skeletal Maturation, and Bone Mass , 2004, Annals of the New York Academy of Sciences.

[53]  D. Levy,et al.  Chorioamnionitis and cerebral palsy in term and near-term infants , 2004 .

[54]  Takashi Suzuki,et al.  Organization of the human aromatase p450 (CYP19) gene. , 2004, Seminars in reproductive medicine.

[55]  D. Russell,et al.  Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. , 2003, The Journal of clinical endocrinology and metabolism.

[56]  S. Bulun,et al.  Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene , 2003 .

[57]  S. Davis,et al.  Minireview: Aromatase and the Regulation of Estrogen Biosynthesis-Some New Perspectives. , 2001, Endocrinology.

[58]  G. Chrousos,et al.  The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. , 1998, The Journal of clinical endocrinology and metabolism.

[59]  P. Jaeger,et al.  Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. , 1997, The Journal of clinical endocrinology and metabolism.

[60]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[61]  M. Shozu,et al.  A new cause of female pseudohermaphroditism: placental aromatase deficiency. , 1991, The Journal of clinical endocrinology and metabolism.

[62]  P. Silveyra,et al.  Estrogen receptor signaling mechanisms. , 2019, Advances in protein chemistry and structural biology.

[63]  K. Hasegawa,et al.  Female pseudohermaphroditism associated with maternal steroid cell tumor, not otherwise specified of the ovary: a case report and literature review. , 2013, Clinical and experimental obstetrics & gynecology.

[64]  M. Wabitsch,et al.  Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred. , 2005, The Journal of clinical endocrinology and metabolism.